Table 2. Base Case Resultsa.
| Variable | Cost (95% CI), $ | QALYs (95% CI) |
|---|---|---|
| 37-mo Follow-up | ||
| ADT plus PRT | 114.223 (95 809 to 132 636) | 1.62 (1.55 to 1.69) |
| PRT | 94 751 (79 476 to 110 025) | 1.78 (1.70 to 1.86) |
| Net difference | −19 472 (−16 333 to −22 611) | 0.16 (0.15 to 0.17) |
| Lifetime follow-up | ||
| ADT plus PRT | 328 971 (251 340 to 406 602) | 2.22 (2.01 to 2.43) |
| PRT | 298 741 (228 244 to 369 238) | 3.03 (2.74 to 3.32) |
| Net difference | −30 229 (−23 096 to −37 362) | 0.81 (0.73 to 0.89) |
Abbreviations: ADT, androgen deprivation therapy; PRT, prostate radiation therapy; QALYs, quality-adjusted life-years.
The 95% CIs were calculated with 10 000 individual trials.